Bioxytran, Inc
BIXT· OTC
BIXTBioxytran, Inc
Filed May 23, 2022 · 10-Q · 53 days after period end · 0001539497-22-001047
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Net Income | -$963.39K | -$1.78M | -$540.50K | -$191.41K |
| EPS Diluted | — | -$0.02 | -$0.01 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioxytran, Inc · CIK 1445815 · Engraved from SEC EDGAR
ended Mar 31, 2022 · filed May 23, 2022 · 53 d after period end
